Download PDF
Minim Invasive Neurosurg 2005; 48(3): 142-148
DOI: 10.1055/s-2004-830266
Original Article
© Georg Thieme Verlag Stuttgart · New York

Gliosarcoma Cell Death After Radiosurgery in a Rat Model

T.  G.  Psarros1 , B.  Mickey1 , J.  Gilio1 , J.  Drees1 , K.  Gall1 , D.  Carlson2 , C.  Giller1 , M.  S.  Willis2, 3
  • 1Department of Neurosurgery, University of Texas Southwestern, Dallas, Texas, USA
  • 2Department of Surgery, University of Texas Southwestern, Dallas, Texas, USA
  • 3Department of Pathology, University of Texas Southwestern, Dallas, Texas, USA
Further Information

Publication History

Publication Date:
13 July 2005 (online)

    Permissions and Reprints

Abstract

Therapeutic radiation and subsequent detection of tumor cell death has been performed mainly in vitro systems, making it difficult to accurately characterize the mechanisms of tumor cell death after radiosurgery. To better characterize what occurs to glioma cells after radiation therapy, we developed a rat model using the 9L gliosarcoma cell line implanted reproducibly to the caudate nucleus in rats. After 1 Gy radiation, 9L tumors in vivo induced mainly necrosis (determined by trypan blue exclusion) of 10 - 74 % at 6 - 72 hours post-radiation. This is in contrast to a previous in vitro study which demonstrated that 18 Gy of radiation induces considerably less cell death as determined by trypan blue exclusion (approximately 20 - 25 % at 6 - 72 hours post-radiation). However, significant amounts of apoptosis were detected as early as 6 hours after radiation. Apoptosis determination was by annexin V (marker of early apoptosis) and propidium iodide (marker of membrane stability) staining followed by flow cytometry detection. When caspase 3 and caspase 8 enzymatic activities (mediators of apoptosis) were measured from freshly explanted tumor cells, peak activity was found 6 hours after 1 Gy radiation (p < 0.01). Taken together, these data indicate the presence of apoptosis early after radiation therapy (1 Gy) which progressed to necrosis in a unique in vivo model of gliosarcoma that may prove useful in determining new therapeutic approaches to radiation therapy and tumor cell biology.

Key words

9L gliosarcoma - radiosurgery - cell death - apoptosis

References

  • 1 Verheij M, Bartelink H. Radiation-induced apoptosis.  Cell Tissue Res. 2000;  301 133-142
    PubMedGoogle Scholar
  • 2 Bristow R G, Benchimol S, Hill R P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy.  Radiother Oncol. 1996;  40 197-223
    CrossrefPubMedGoogle Scholar
  • 3 Kastan M B, Onyekwere O, Sidransky D. et al . Participation of p53 protein in the cellular response to DNA damage.  Cancer Res. 1991;  51 6304-6311
    PubMedGoogle Scholar
  • 4 Barker M, Hoshino T, Gurcay O. et al . Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.  Cancer Res. 1973;  33 976-986
    PubMedGoogle Scholar
  • 5 Adler jr J R, Chang S D, Murphy M J. et al . The Cyberknife: a frameless robotic system for radiosurgery.  Stereotact Funct Neurosurg. 1997;  69 124-128
    PubMedGoogle Scholar
  • 6 Chang S D, Adler J R. Robotics and radiosurgery - the cyberknife.  Stereotact Funct Neurosurg. 2001;  76 204-208
    PubMedGoogle Scholar
  • 7 Koopman G, Reutelingsperger C P, Kuijten G A. et al . Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.  Blood. 1994;  84 1415-1420
    PubMedGoogle Scholar
  • 8 Martin S J, Reutelingsperger C P, McGahon A J. et al . Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.  J Exp Med. 1995;  182 1545-1556
    CrossrefPubMedGoogle Scholar
  • 9 Schwartz P S, Waxman D J. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.  Mol Pharmacol. 2001;  60 1268-1279
    PubMedGoogle Scholar
  • 10 Stapper N J, Stuschke M, Sak A. et al . Radiation-induced apoptosis in human sarcoma and glioma cell lines.  Int J Cancer. 1995;  62 58-62
    PubMedGoogle Scholar
  • 11 Ciapetti G, Granchi D, Cenni E. et al . Cytotoxic effect of bone cements in HL-60 cells: distinction between apoptosis and necrosis.  J Biomed Mater Res. 2000;  52 338-345
    PubMedGoogle Scholar
  • 12 Hamatake M, Iguchi K, Hirano K. et al . Zinc induces mixed types of cell death, necrosis, and apoptosis, in molt-4 cells.  J Biochem (Tokyo). 2000;  128 933-939
    PubMedGoogle Scholar
  • 13 Mazur L, Bochenek M, Augustynek A. Phosphatidylserine externalization during bone marrow cell death after treatment of mice with WR-2721 and gamma-rays.  Folia Biol (Krakow). 2002;  50 95-100
    PubMedGoogle Scholar
  • 14 Willis M S, Klassen L W, Tuma D J. et al . Malondialdehyde-acetaldehyde-haptenated protein induces cell death by induction of necrosis and apoptosis in immune cells.  Int Immunopharmacol. 2002;  2 519-535
    PubMedGoogle Scholar
  • 15 Graham R M, Frazier D P, Thompson J W. et al . A unique pathway of cardiac myocyte death caused by hypoxia-acidosis.  J Exp Biol. 2004;  207 3189-3200
    CrossrefPubMedGoogle Scholar
  • 16 Kurita H, Ostertag C B, Baumer B. et al . Early effects of PRS-irradiation for 9L gliosarcoma: characterization of interphase cell death.  Minim Invas Neurosurg. 2000;  43 197-200
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Konemann S, Bolling T, Schuck A. et al . Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile.  Int J Radiat Biol. 2003;  79 181-192
    CrossrefPubMedGoogle Scholar
  • 18 Glucksmann A. Cell death in normal vertebrate ontogeny.  Biol Rev. 1951;  26 59-86
    PubMedGoogle Scholar
  • 19 Miller E. Apoptosis measurement by annexin v staining.  Methods Mol Med. 2004;  88 191-202
    PubMedGoogle Scholar
  • 20 Darzynkiewicz Z, Bruno S, Del Bino G. et al . Features of apoptotic cells measured by flow cytometry.  Cytometry. 1992;  13 795-808
    PubMedGoogle Scholar
  • 21 Gorczyca W, Gong J, Ardelt B. et al . The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various anti-tumor agents.  Cancer Res. 1993;  53 3186-3192
    PubMedGoogle Scholar
  • 22 Schmid I, Uittenbogaart C H, Giorgi J V. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry.  Cytometry. 1994;  15 12-20
    PubMedGoogle Scholar
  • 23 Stuart M C, Damoiseaux J G, Frederik P M. et al . Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes.  Eur J Cell Biol. 1998;  76 77-83
    PubMedGoogle Scholar
  • 24 Engeland M van, Nieland L J, Ramaekers F C. et al . Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.  Cytometry. 1998;  31 1-9
    PubMedGoogle Scholar
  • 25 Engeland M van, Ramaekers F C, Schutte B. et al . A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.  Cytometry. 1996;  24 131-139
    PubMedGoogle Scholar
  • 26 Zhang G, Gurtu V, Kain S R. et al . Early detection of apoptosis using a fluorescent conjugate of annexin V.  Biotechniques. 1997;  23 525-531
    PubMedGoogle Scholar
  • 27 Kern J C, Kehrer J P. Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis.  Chem Biol Interact. 2002;  139 79-95
    PubMedGoogle Scholar
  • 28 Zeiss C J. The apoptosis-necrosis continuum: insights from genetically altered mice.  Vet Pathol. 2003;  40 481-495
    CrossrefPubMedGoogle Scholar
  • 29 Alderson L M, Castleberg R L, Harsh G RT. et al . Human gliomas with wildtype p53 express bcl-2.  Cancer Res. 1995;  55 999-1001
    PubMedGoogle Scholar
  • 30 Lang F F, Yung W K, Sawaya R. et al . Adenovirus-mediated p53 gene therapy for human gliomas.  Neurosurgery. 1999;  45 1093-1104
    CrossrefPubMedGoogle Scholar
  • 31 Vogelbaum M A, Tong J X, Perugu R. et al . Overexpression of bax in human glioma cell lines.  J Neurosurg. 1999;  91 483-489
    PubMedGoogle Scholar
  • 32 Hao C, Beguinot F, Condorelli G. et al . Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.  Cancer Res. 2001;  61 1162-1170
    PubMedGoogle Scholar
  • 33 Knight M J, Riftkin C D, Muscat A M. et al . Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.  Oncogene. 2001;  20 5789-5798
    CrossrefPubMedGoogle Scholar
  • 34 Seol D W, Li J, Seol M H. et al . Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.  Cancer Res. 2001;  61 1138-1143
    PubMedGoogle Scholar
  • 35 Song J H, Song D K, Pyrzynska B. et al . TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.  Brain Pathol. 2003;  13 539-553
    PubMedGoogle Scholar
  • 36 Xiao C, Yang B F, Asadi N. et al . Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells.  J Bioi Chem. 2002;  277 25 020-25 025
    PubMedGoogle Scholar
  • 37 Chambers W H, Bozik M E, Brissette-Storkus S C. et al . NKR-P1+ cells localize selectively in rat 9L gliosarcomas but have reduced cytolytic function.  Cancer Res. 1996;  56 3516-3525
    PubMedGoogle Scholar
  • 38 Lichtor T, Glick R P. Cytokine immuno-gene therapy for treatment of brain tumors.  J Neurooncol. 2003;  65 247-259
    CrossrefPubMedGoogle Scholar
  • 39 Shah M R, Ramsey W J. CD8+ T-cell mediated anti-tumor responses cross-reacting against 9L and RT2 rat glioma cell lines.  Cell Immunol. 2003;  225 113-121
    CrossrefPubMedGoogle Scholar
  • 40 Held K D. Radiation-induced apoptosis and its relationship to loss of clonogenic survival.  Apoptosis. 1997;  2 265-282
    CrossrefPubMedGoogle Scholar
  • 41 Rodriguez A, Alpen E L, Mendonca M. et al . Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.  Radiat Res. 1988;  114 515-527
    PubMedGoogle Scholar
  • 42 Pawlik T M, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy.  Int J Radiat Oncol Bioi Phys. 2004;  59 928-942
    PubMedGoogle Scholar
  • 43 Skog S, Tribukait B. Cell size following irradiation in relation to cell cycle.  Acta Radiol Oncol. 1986;  25 269-273
    PubMedGoogle Scholar
  • 44 Andersen A P. Postoperative irradiation of glioblastomas. Results in a randomized series.  Acta Radiol Oncol Radiat Phys Biol. 1978;  17 475-484
    PubMedGoogle Scholar
  • 45 Sheline G E. Radiation therapy of brain tumors.  Cancer. 1977;  39 873-881
    PubMedGoogle Scholar

Tom G. Psarros,M. D. 

Department of Neurosurgery · University of Texas Southwestern

5323 Harry Hines Blvd.

Dallas, TX 75390-885

USA

Email: tompsarros@aol.com

      >